These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 20189073

  • 1. Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET.
    Lin CY, Ding HJ, Lin T, Lin CC, Kuo TH, Kao CH.
    Clin Imaging; 2010; 34(2):109-12. PubMed ID: 20189073
    [Abstract] [Full Text] [Related]

  • 2. Impact of age on FDG uptake in the liver on PET scan.
    Lin CY, Ding HJ, Lin CC, Chen CC, Sun SS, Kao CH.
    Clin Imaging; 2010; 34(5):348-50. PubMed ID: 20813297
    [Abstract] [Full Text] [Related]

  • 3. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
    Kanstrup IL, Klausen TL, Bojsen-Møller J, Magnusson P, Zerahn B.
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
    [Abstract] [Full Text] [Related]

  • 4. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT, Fung CI.
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [Abstract] [Full Text] [Related]

  • 5. The significance of alteration 2-[fluorine-18]fluoro-2-deoxy-(D)-glucose uptake in the liver and skeletal muscles of patients with hyperthyroidism.
    Chen YK, Chen YL, Tsui CC, Wang SC, Cheng RH.
    Acad Radiol; 2013 Oct; 20(10):1218-23. PubMed ID: 24029053
    [Abstract] [Full Text] [Related]

  • 6. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET.
    Lin CY, Lin WY, Lin CC, Shih CM, Jeng LB, Kao CH.
    Clin Imaging; 2011 Oct; 35(6):437-41. PubMed ID: 22040787
    [Abstract] [Full Text] [Related]

  • 7. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K.
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [Abstract] [Full Text] [Related]

  • 11. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [Abstract] [Full Text] [Related]

  • 12. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
    Keramida G, Potts J, Bush J, Verma S, Dizdarevic S, Peters AM.
    AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
    [Abstract] [Full Text] [Related]

  • 13. Findings of 2-fluoro-2-deoxy-d-glucose positron emission tomography in hemorrhoids.
    Tsai SC, Jeng LB, Yeh JJ, Lin CC, Chen JH, Lin WY, Kao CH.
    Abdom Imaging; 2011 Oct; 36(5):548-51. PubMed ID: 21153025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
    van Westreenen HL, Cobben DC, Jager PL, van Dullemen HM, Wesseling J, Elsinga PH, Plukker JT.
    J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
    [Abstract] [Full Text] [Related]

  • 17. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH.
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ.
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [Abstract] [Full Text] [Related]

  • 20. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.